Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of acylaminobenzoic acids and derivatives. It is known as an experimental inhibitor of protein tyrosine phosphatase, non-receptor type 1 (PTPN1 or PTP1B), a key negative regulator of insulin and leptin signaling pathways. By inhibiting PTPN1, this molecule has been investigated for its potential in modulating metabolic disorders such as diabetes and obesity, though it has not advanced to clinical development or approval[10][5][8]. The compound is referenced in chemical databases under CHEMBL1230658 and DrugBank DB01820.
- Other names
- 2-(1-carboxy-N-(4-((2S)-2-acetamido-2-(pentylcarbamoyl)ethyl)naphthalen-1-yl)formamido)benzoic acid2-[{4-[2-Acetamido-3-oxo-3-(pentylamino)propyl]-1-naphthyl}(carboxycarbonyl)amino]benzoic acid
02
Targets
PTPN1 (Protein tyrosine phosphatase 1B)
Beyond the preview
Go deeper on 2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid.